ELAC2 and cancer: The higher level of nuclear ELAC2 staining in cancers (35% with moderate to strong staining) as compared to normal prostate epithelial tissue (typically negative or only weakly positive) suggests that nuclear ELAC2 becomes up-regulated during malignant transformation in a subset of prostate cancers.